ClinicalTrials.Veeva

Menu

Lidocaine Injection Versus Sham Needling in Treating Whiplash Associated Disorder

H

Hamilton Health Sciences (HHS)

Status and phase

Withdrawn
Phase 4

Conditions

Neck Pain
Whiplash Injuries

Treatments

Procedure: Lidocaine
Other: Saline

Study type

Interventional

Funder types

Other

Identifiers

NCT02060734
HHSCTRIGGERINJ1402

Details and patient eligibility

About

To determine the efficacy of lidocaine injection of trigger points versus subcutaneous injection in patients with subacute whiplash associated disorder following injury.

Full description

This is a double-blind, randomized controlled trial to determine the efficacy of lidocaine injection of trigger points versus subcutaneous injection in patients with subacute whiplash associated disorder following injury. Outcomes include pain, objective assessment, self-report function recovery, impact on work performance and globe perceived effects which will be assessed 5 minutes, 2 and 6 weeks following injection.

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • fulfill the Grade II Quebec Task Force classification of WAD,
  • with identifiable myofascial trigger points ( which occur with or without a taut band),
  • reproduction of recognizable pain with sustained pressure ( up to 10 seconds) on trigger points
  • aged 18 to 70
  • a good understanding of informed consent and willing to attend this trial.

Exclusion criteria

  • have serious injury such as fracture and internal bleeding
  • suspicion of upper cervical instability or neurological deficits
  • clinical evidence of radiculopathy
  • a history of active cancer, central nerve disorder, blood clotting disorders, needle phobia
  • anticoagulant medication user
  • previous experience with any type of needling for myofascial pain

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

0 participants in 2 patient groups

lidocaine
Experimental group
Description:
The treatment group will receive a 25 gauge, 40mm long needle, pre-filled with 1% lidocaine inserting into the site of the trigger point. Three to five points injection.
Treatment:
Procedure: Lidocaine
Saline
Active Comparator group
Description:
The control group will receive a 25 gauge, 40mm long needle, pre-filled with saline inserting to subcutis.
Treatment:
Other: Saline

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems